Holen Sie sich die Stockscreener-App
31.07
0.73%
-0.13
Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
6.82%
4.851
|
5.206 | 7.274 | 7.787 | 8.73 |
| Interest Income/Expense |
40.00%
0.006
|
0.01 | 0.013 | 0.024 | 0.028 |
| Operating Income/Loss |
6.82%
-4.851
|
-5.206 | -7.274 | -7.787 | -8.73 |
| Income/Loss From Continuing Operations Before Tax |
7.44%
-4.569
|
-4.936 | -6.864 | -7.142 | -7.992 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
7.44%
-4.569
|
-4.936 | -6.864 | -7.142 | -7.992 |
Net Income/Loss
|
7.44%
-4.569
|
-4.936 | -6.864 | -7.142 | -7.992 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.03%
1.2613
|
1.2609 | 25.19 | 25.10 | 25.05 |
| Diluted Average Shares |
0.03%
1.2613
|
1.2609 | 25.19 | 25.10 | 25.05 |
| Basic Earnings Per Share |
7.42%
-3.62
|
-3.91 | -0.27 | -0.28 | -0.32 |
| Diluted Earnings Per Share |
7.42%
-3.62
|
-3.91 | -0.27 | -0.28 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):